Responsible for the development of protocols and guidelines for the St Lukes Cancer Centre and partner Cancer Units (ASPH, FPH and SASH) in collaboration with Consultant Oncologists/Haematologists. These reference the latest clinical evidence and commissioning guidance. They include: o Tumour site specific treatment algorithmso Systemic anti-cancer therapy (SACT) treatment protocolso Supportive care protocolso Guidelines/protocols for the delivery of SACTo Guidelines/protocols for SACT-related acute oncology presentationso General SACT prescribing guidelinese.g. assessment of renal function, monitoring patient weight Responsible for monitoring deviations from the agreed treatment algorithms/protocols (off protocol reporting).
Responsible for the provision of training to medical, nursing and pharmacy staff on SACT treatment algorithms/protocols and supportive care/toxicity management guidelines. Responsible for the identification of new drug treatments or clinical guidance within the specialty that have financial implications, and support the management or implementation of these within the Trust (i.e. Horizon Scanning) in liaison with Deputy Chief Pharmacist Cancer, Aseptic and Research Services. Responsible for the new medicines entry process for SACT (including compassionate use) and associated supportive care medicines, involving liaison with other areas of Pharmacy e.g.o Pharmacy Procuremento Pharmacy Aseptic Unito Pharmacy Dispensary (RSCH Pharmacy Limited)o Lead Electronic Prescribing Pharmacist (Chemotherapy) Responsible for the development of SACT regimen-specific consent forms in collaboration with Consultant Oncologists/Haematologists.
Liaise with commissioners as required to ensure the Cancer Centre is operating within latest commissioning guidance e.g. NHS England / local Clinical Commissioning Groups. Act as a resource in dealing with complex and contentious issues surrounding the use of high cost drugs, including the resolution of commissioner data challenges. Where required, ensure that commissioner approval at individual patient level is in place prior to treatment initiation.
Identify areas of potential cost-savings within the specialty and implement systems to realise savings and contain prescribing costs. Work as a highly specialised practitioner, with tumour-site specific teams as required, to contribute to the delivery a comprehensive clinical pharmacy service to oncology, haemato-oncology and palliative care patients in accordance with objectives set by the Deputy Chief Pharmacist Cancer, Aseptic and Research Services. Provide specialist clinical cancer pharmacist support to NHS England National Teams and the South East Regional Team with scope and responsibilities as defined in a separate Service Level Agreement (0.2WTE commitment)

Please refer the Job description for details